habitual snoring, asthma, allergic rhinitis sleep-disordered breathing, pediatric, respiratory allergy clinic
Conditions
Interventions
The group of patients with intranasal corticosteroids or leukotriene receptor antagonist administration.,The group of patients with intranasal corticosteroids and leukotriene receptor antagonist admin
Treatment,Treatment
monotherapy group,combined therapy group
Sponsors
None listed
Eligibility
Sex/Gender
All
Age
1 Years to 15 Years
Inclusion criteria
Inclusion criteria: A prospective cohort study was conducted on pediatric patients 1-15 years of age with respiratory allergies who were treated in the allergy clinic of Buddhasothorn hospital. All of them have been diagnosed with asthma and/or allergic rhinitis.
Exclusion criteria
Exclusion criteria: The patients had underlying chronic diseases bronchopulmonary dysplasia (interstitial lung disease, congenital heart disease, or congenital anomalies).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| step 1 treatment intranasal corticosteroids or leukotriene receptor antagonist at 12 months after end of the study The visual analogue scale (VAS) of allergic rhinitis and OSA-18 quality-of-life questionnaire | — |
Secondary
| Measure | Time frame |
|---|---|
| step 2 treatment intranasal corticosteroids with Leukotriene receptor antagonists (LTRA) at 12 months after end of the study The visual analogue scale (VAS) of allergic rhinitis and OSA-18 quality-of-life questionnaire | — |
Countries
Thailand
Contacts
Public ContactSuttipong Ittiporn
Buddhasothorn Hospital
Outcome results
None listed